4 Ensemble Capital Teva- Pharmaceutical Industries Ltd. - ADR Trades
Ensemble Capital started to build up the position in Teva- Pharmaceutical Industries Ltd. - ADR in Q1 2013. Since then they sold 183 Thousand shares. The investor completely sold their stake between Q2 2013 and Q4 2013.
Avg closing price
Price range
Sold -39.1 Thousand shares
Q4 2013
Avg closing price
$39.38
Price range
$36.59
-
$41.70
Sold 57.6% shares (-53.1 Thousand shares)
Q3 2013
Avg closing price
$39.00
Price range
$37.43
-
$41.27
Sold 49.5% shares (-90.5 Thousand shares)
Q2 2013
Avg closing price
$38.94
Price range
$37.80
-
$40.23
New holding (+183 Thousand shares)
Q1 2013
Avg closing price
$38.59
Price range
$37.19
-
$41.06
News about Teva- Pharmaceutical Industries Ltd. - ADR and Ensemble Capital
Tracking David Abrams'' Abrams Capital Management Portfolio - Q4 2023 Update
David Abrams'' 13F portfolio value rises to $3.22B, while Meta Platforms and Teva Pharmaceutical witness stake reductions. Explore more here.
Marathon Capital Management Sells 2,500 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Marathon Capital Management reduced its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 10.6% during the 2nd quarter, according to the company...